Ontology highlight
ABSTRACT: Background
Adverse drug reactions and medication nonadherence are well-known causes of sub-optimal disease control and worsened disease outcomes in patients who are treated for type 2 diabetes. Metformin sustained release (SR) might reduce these adverse events and improve medication adherence via a simplified treatment regimen for metformin immediate release (IR)-intolerant patients.Objectives
The aim of this study is to estimate the budget impact of metformin SR for the treatment of type 2 diabetes in the Netherlands, compared to the current standard of care (SoC) with metformin IR.Methods
A budget impact model was built to represent the course of the disease and treatment pathway of type 2 diabetes patients eligible for metformin SR from a healthcare payer's persp
SUBMITTER: Gout-Zwart JJ
PROVIDER: S-EPMC7248141 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature